EHR market exceeded $20B in 2012

The EHR market exceeded $20 billion in 2012, according to Kalorama Information. The healthcare market research publisher says vendors should see robust sales this year and next as providers try to avoid U.S. government penalties for paper record use. Kalorama detailed the finding in its sixth annual report on the EHR market, EMR 2013: The Market for Electronic Medical Records.

Kalorama Information’s report said the EHR market reached $20.7 billion in 2012, a 15 percent increase from its 2011 $17.9 billion value. Kalorama includes revenues for EMR/EHR systems, CPOE systems and directly related services such as installation, training, servicing and consulting, which are key profit areas for companies, but does not include hardware or other IT systems unrelated to EMR such as billing systems.   

“Last year was particularly good for the EMR market,” said Bruce Carlson, publisher of Kalorama Information in a release. “Companies improved sales to physicians, while hospitals added upgraded systems to conform with Meaningful Use requirements.”

More than $12.3 billion in Meaningful Use incentive payments have been distributed to 219,000 eligible hospitals and healthcare professionals as of March 1. The incentives are driving physician adoption, according to the Kalorama report.    

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?